phosphotyrosine has been researched along with Acquired Immune Deficiency Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaral, MC; Kumar, G; Miles, S; Nel, AE | 1 |
| Bonmann, M; Kiehl, M; Koch, OM; Müller, C; Patzke, J | 1 |
| Albini, A; Arena, G; Benelli, R; Carlone, S; Giunciuglio, D; Morini, M; Noonan, DM | 1 |
3 other study(ies) available for phosphotyrosine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth.
Topics: Acquired Immunodeficiency Syndrome; Benzoquinones; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cell Membrane; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Enzyme Activation; Growth Inhibitors; Humans; Kinetics; Lactams, Macrocyclic; Mitogen-Activated Protein Kinase 1; Oncostatin M; Peptides; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Quinones; Sarcoma, Kaposi; Thymidine; Tumor Cells, Cultured; Tyrosine; Umbilical Veins | 1993 |
Alterations of protein tyrosine phosphorylation in T cells of immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Bone Marrow Transplantation; Flow Cytometry; Heart Transplantation; Humans; Immunocompromised Host; Leukocytes, Mononuclear; Lymphocyte Activation; Muromonab-CD3; Phosphorylation; Phosphotyrosine; Proteins; T-Lymphocytes | 1998 |
Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Topics: Acquired Immunodeficiency Syndrome; Antibodies; Chemotactic Factors; Chemotaxis; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Activation; Gene Products, tat; Humans; Lymphokines; Phosphorylation; Phosphotyrosine; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Sarcoma, Kaposi; Signal Transduction; tat Gene Products, Human Immunodeficiency Virus; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |